Skip to content
  • info@BioLifeSolutions.com
  • 1.866.424.6543
  • Toggle search form
  • Toggle shopping cart 0

    Cart

  • Products
    • CryoStor®
      • CryoStor CS10
      • CryoStor CS5
      • CryoStor CS2
      • CryoStor CSB
    • HypoThermosol®
      • HypoThermosol®
      • HypoThermosol for Hair
    • ThawSTAR® Products
      • ThawSTAR CB
      • ThawSTAR CFT2
      • AT6
      • CFT1.5
      • CFT2 Confirmation Vials
      • Warranty and PM
      • IOP Qualification Packet
      • BioT ULT Transporter
      • BioT LN2 Transporter
      • BioT ULT Mobile Workstation
    • BloodStor®
      • BloodStor 100
      • BloodStor 55-5
      • BloodStor 27
    • Cell Thawing Media®
      • 10% Dextran 40 (IN 0.9% NaCl)
      • 10% Dextran 40 (IN 5% Dextrose)
    • All Products
  • Resources
    • Certificate of Analysis
    • Blog
    • Events
    • BioPreservation Today
    • White Papers
    • Press Releases
  • Evidence
    • Resource Links
  • Company
    • About
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Quality Management System
    • Distributors
    • Current Job Openings
  • Investors
    • Investors Home
    • Governance
    • Press Releases
    • Financials
    • Stock Information
    • Management Team
    • Investor Contact
  • Contact
    • General Inquiries
    • ThawSTAR Inquiries
    • Master File Request
    • SDS Request Form
    • Sample Request
    • evo Support Request
  • Ask the Scientists
  • ORDER
Close navigation
  • Primary Menu
logo

BioLife Solutions

Biopreservation Tools For Cells, Tissues, and Organs

Close search

Search

Search for:
Home/Blog/Tag: “Growth”

Tag: Growth

The importance of cell culture parameter standardization: an assessment of the robustness of the 2102Ep reference cell line

Kusena, J. W. T., Shariatzadeh, M., Studd, A. J., James, J. R., Thomas, R. J. and Wilson, S. L.  The importance of cell culture parameter standardization: an assessment of the robustness of the 2102Ep reference cell line.  Bioengineered. 2021; 12(1), 341-357.  doi: 10.1080/21655979.2020.1870074

Read More

Plant cell-secreted stem cell factor stimulates expansion and differentiation of hematopoietic stem cells

Wang, X., Karki, U., Abeygunaratne, H., UnnoldCofre, C. and Xu, J.  Plant cell-secreted stem cell factor stimulates expansion and differentiation of hematopoietic stem cells.  Process Biochemistry. 2021; 100, 39-48.  doi: 10.1016/j.procbio.2020.09.029

Read More

Inflammatory and stem-like colorectal cancer (CRC) subtypes identified in patient-derived xenograft (PDX) models show tumor growth inhibition (TGI) by the combination of trametinib (T) and neratinib (N) irrespective of KRAS mutation (MT) status

Inflammatory and stem-like colorectal cancer (CRC) subtypes identified in patient-derived xenograft (PDX) models show tumor growth inhibition (TGI) by the combination of trametinib (T) and neratinib (N) irrespective of KRAS mutation (MT) status

Read More

Lym-1 Chimeric Antigen Receptor T Cells Exhibit Potent Anti Tumor Effects against B-Cell Lymphoma

Zheng, Hu, Wolfe, Gonsalves, Ren, Khawli, Kaslow, Epstein. Lym-1 Chimeric Antigen Receptor T Cells Exhibit Potent Anti Tumor Effects against B-Cell Lymphoma. Int. J. Mol. Sci. 2017, 18, 2773. doi:10.3390/ijms18122773

Read More

Human Mesenchymal Stem Cell Growth on Corning Denatured Collagen Dissolvable Microcarriers in a 5L Bioreactor 

Weber, Romeo, Dolley-Sonneville. Human Mesenchymal Stem Cell Growth on Corning Denatured Collagen Dissolvable Microcarriers in a 5L Bioreactor. Corning Incorporated, Life Sciences, Corning, NY USA

Read More

Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility

Kunkele A, Taraseviciute A, Finn L, Johnson A, et al. Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility Clin Cancer Res; 23(2) January 15, 2017 DOI: 10.1158/1078-0432.CCR-16-0354

Read More

Intent to treat leukemia remission by CD19CAR T cells of defined formulation and dose in children and young adults

Gardner R, Finney O, Annesley C, Brakke H, Summers C, Leger K, Bleakley M, Brown C, Mgebroff S, Spratt K, Hoglund V, Lindgren C, Oron A, Li D, Riddell S, Park J, Jensen M. Intent to treat leukemia remission by CD19CAR T cells of defined formulation and dose in children and young adults. Blood 2017 :blood-2017-02-769208. doi:…

Read More

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy

Brown C, Alizadeh D, Starr R, Weng L, Wagner J, et al. Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy. N Engl J Med 2016;375:2561-9 DOI: 10.1056/NEJMoa1610497

Read More

A Rapid Cell Expansion Process for Production of Engineered Autologous CAR-T Cell Therapies

Lu T, Pugach O, Somerville R, Rosenberg S, Kochendefer J, Better M, Feldman S A Rapid Cell Expansion Process for Production of Engineered Autologous CAR-T Cell Therapies HUMAN GENE THERAPY METHODS, VOLUME 27 NUMBER 6 DOI: 10.1089/hgtb.2016.120

Read More
Search for:

Blog Archives

Signup Area

    Sign Up for Email Updates

    Biolife Logo

    • Products
    • Company
    • Evidence
    • Investors
    • Blog
    • Ask the Scientists
    • Press Releases
    • Contact
    © 2019 BioLifeSolutions Inc.  All Rights Reserved    |    Terms & Conditions    |    Privacy
    • twitter
    • linkedin
    • facebook